ATE224443T1 - Mch2, eine apoptotische cystein-protease, zusammensetzungen für ihre präparation und methoden für ihre verwendung - Google Patents

Mch2, eine apoptotische cystein-protease, zusammensetzungen für ihre präparation und methoden für ihre verwendung

Info

Publication number
ATE224443T1
ATE224443T1 AT96920234T AT96920234T ATE224443T1 AT E224443 T1 ATE224443 T1 AT E224443T1 AT 96920234 T AT96920234 T AT 96920234T AT 96920234 T AT96920234 T AT 96920234T AT E224443 T1 ATE224443 T1 AT E224443T1
Authority
AT
Austria
Prior art keywords
mch2
disclosed
alpha
beta
nucleic acid
Prior art date
Application number
AT96920234T
Other languages
English (en)
Inventor
Gerald Litwack
Emad S Alnemri
Teresa Fernandez-Alnemri
Original Assignee
Univ Jefferson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Jefferson filed Critical Univ Jefferson
Application granted granted Critical
Publication of ATE224443T1 publication Critical patent/ATE224443T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6472—Cysteine endopeptidases (3.4.22)
    • C12N9/6475—Interleukin 1-beta convertase-like enzymes (3.4.22.10; 3.4.22.36; 3.4.22.63)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Detergent Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT96920234T 1995-05-18 1996-05-16 Mch2, eine apoptotische cystein-protease, zusammensetzungen für ihre präparation und methoden für ihre verwendung ATE224443T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/446,925 US5672500A (en) 1995-05-18 1995-05-18 Mch2, an apoptotic cysteine protease, and compositions for making and methods of using the same
PCT/US1996/007010 WO1996036698A1 (en) 1995-05-18 1996-05-16 Mch2, AN APOPTOTIC CYSTEINE PROTEASE, AND COMPOSITIONS FOR MAKING AND METHODS OF USING THE SAME

Publications (1)

Publication Number Publication Date
ATE224443T1 true ATE224443T1 (de) 2002-10-15

Family

ID=23774339

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96920234T ATE224443T1 (de) 1995-05-18 1996-05-16 Mch2, eine apoptotische cystein-protease, zusammensetzungen für ihre präparation und methoden für ihre verwendung

Country Status (8)

Country Link
US (4) US5672500A (de)
EP (1) EP0842267B1 (de)
JP (1) JPH11505705A (de)
AT (1) ATE224443T1 (de)
CA (1) CA2221409C (de)
DE (1) DE69623786T2 (de)
ES (1) ES2183960T3 (de)
WO (1) WO1996036698A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6060238A (en) * 1995-02-13 2000-05-09 The Regents Of The University Of Michigan Method and composition for regulating apoptosis
US6015665A (en) * 1995-02-13 2000-01-18 The Regents Of The University Of Michigan Method and composition for regulating apoptosis
US7097972B1 (en) 1995-02-13 2006-08-29 Regents Of The University Of Michigan Method and composition for regulating apoptosis
US6747138B1 (en) 1995-04-03 2004-06-08 Regents Of The University Of Michigan Methods and compositions for regulating Fas-associated apoptosis
US7807783B1 (en) 1995-04-03 2010-10-05 The Regents Of The University Of Michigan Methods and compositions for regulating FAS-associated apoptosis
US5672500A (en) 1995-05-18 1997-09-30 Thomas Jefferson University Mch2, an apoptotic cysteine protease, and compositions for making and methods of using the same
US6635738B2 (en) 1996-03-04 2003-10-21 The Trustees Of Columbia University In The City Of New York Compounds which prevent neuronal cell death and uses thereof
US6558900B2 (en) * 1996-07-12 2003-05-06 Emory University Regulation of apoptosis and in vitro model for studies thereof
WO1998043621A1 (en) * 1997-03-31 1998-10-08 The Children's Medical Center Corporation Nitrosylation to inactivate apoptotic enzymes
US6455296B2 (en) * 1997-05-29 2002-09-24 Thomas Jefferson University Apoptotic protease Mch6, nucleic acids encoding same and methods of use
US6270980B1 (en) * 1997-06-05 2001-08-07 Idun Pharmaceuticals, Inc. Rapid methods for identifying modifiers of cellular apoptosis activity
CN1300828A (zh) * 1999-12-22 2001-06-27 上海博德基因开发有限公司 一种新的多肽－半胱氨酸蛋白酶10和编码这种多肽的多核苷酸
US6566135B1 (en) * 2000-10-04 2003-05-20 Isis Pharmaceuticals, Inc. Antisense modulation of caspase 6 expression
DE10241152A1 (de) * 2002-09-05 2004-03-18 GESELLSCHAFT FüR BIOTECHNOLOGISCHE FORSCHUNG MBH (GBF) Tubulysin-Biosynthese-Gene
US7410765B2 (en) * 2004-11-17 2008-08-12 The Regents Of The University Of California System for protease mediated protein expression
US20090238766A1 (en) * 2008-03-19 2009-09-24 Abbott Laboratories Bioluminescent construct

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4873191A (en) * 1981-06-12 1989-10-10 Ohio University Genetic transformation of zygotes
US4736866B1 (en) * 1984-06-22 1988-04-12 Transgenic non-human mammals
US5108921A (en) * 1989-04-03 1992-04-28 Purdue Research Foundation Method for enhanced transmembrane transport of exogenous molecules
CA2158479C (en) * 1993-04-05 2009-07-07 Mark T. Keating Diagnosis and treatment of supravalvular aortic stenosis and williams syndrome
US5672500A (en) * 1995-05-18 1997-09-30 Thomas Jefferson University Mch2, an apoptotic cysteine protease, and compositions for making and methods of using the same

Also Published As

Publication number Publication date
ES2183960T3 (es) 2003-04-01
EP0842267A1 (de) 1998-05-20
EP0842267A4 (de) 2000-04-26
EP0842267B1 (de) 2002-09-18
WO1996036698A1 (en) 1996-11-21
US5985640A (en) 1999-11-16
US5958720A (en) 1999-09-28
DE69623786D1 (de) 2002-10-24
US5672500A (en) 1997-09-30
US6359127B1 (en) 2002-03-19
DE69623786T2 (de) 2003-05-15
CA2221409C (en) 2011-07-26
CA2221409A1 (en) 1996-11-21
JPH11505705A (ja) 1999-05-25

Similar Documents

Publication Publication Date Title
DE69623786D1 (de) Mch2, EINE APOPTOTISCHE CYSTEIN-PROTEASE, ZUSAMMENSETZUNGEN FÜR IHRE PRÄPARATION UND METHODEN FÜR IHRE VERWENDUNG
Wold et al. Identification of cellular proteins required for simian virus 40 DNA replication
Nagy et al. Glyceraldehyde-3-Phosphate dehydrogenase selectively binds AU-rich RNA in the NAD+-binding region (Rossmann fold)(∗)
Walz et al. Generation of the neutrophil-activating peptide NAP-2 from platelet basic protein or connective tissue-activating peptide III through monocyte proteases.
KR960705850A (ko) 사람 쿠니즈형 프로테아제 저해인자(human kunitz-type protease inhibitors)
AR006188A1 (es) "composicion farmaceutica para inhibir la actividad de serinproteasa, metodo in vitro para inhibir la actividad de serinproteasa y metodo para preparar dicha composicion".
ATE79138T1 (de) Typenspezifische papillomavirus-dns-sequenzen und peptide.
MX9708427A (es) Serpina derivada de pancreas.
ES2259190T3 (es) Composiciones y metodos para la biosintesis de taxol.
DE69226636D1 (de) Stabilisierte enzyme
Margoliash Primary structure and evolution of cytochrome c
Lee et al. RNA annealing activity is intrinsically associated with U2AF
Mattick et al. The architecture of the animal fatty acid synthetase. I. Proteolytic dissection and peptide mapping.
KR970707162A (ko) II종 포스포리파제 A2 저해작용을 갖는 신규한 모노클로날 항체 및 그 일부를 포함하는 단백질(Novel monoclonal antibody having inhibitory effect on type II phospholipase A2 and protein containing a part of the same)
DK0458937T3 (da) Varianter af PAI-2
CA2281955A1 (en) Ikb kinase, subunits thereof, and methods of using same
DE60235985D1 (de) Ntb-a, ein oberflächenmolekül impliziert in der aktivität natürlicher killerzellen (nk)
BR9811412A (pt) Variante de enzima subtilase tendo melhorado desempenho de lavagem em detergentes, sequência de dna isolada, vetor de expressão, célula hospedeira microbiana, processos para produzir uma variante e para identificar uma variante de protease, composição, e, uso de uma variante de subtilase
Hiltkel et al. Structure/function analysis of human cystatin SN and comparison of the cysteine proteinase inhibitory profiles of human cystatins C and SN
AR013801A1 (es) Nuevas moleculas de acido nucleico aislada, una proteina de epoxido hidrolasa de artropodo hematofago aislada, una formulacion de proteinas deepoxido hidrolasa de pulga, una composicion terapeutica que reduce la infestacion de ectoparasitos hematofagos; uso de dicha composicion para la
Reddy et al. Nucleotides sequence of the genes for the simian virus 40 proteins VP2 and VP3.
McClelland et al. The calpain—calpastatin system in vascular smooth muscle
Rickli et al. Investigations on the primary structure of human plasminogen further evidence for sequence homology
ATE213773T1 (de) In apoptosis beteiligte cysteine protease cmh-1 und dns-sequenzen dafür
Harris et al. Amino acid sequences in penicillo-pepsin: evidence for homology with porcine pepsin and chymosin

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties